| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |